Drug makers may profit from disease in global warming scourge

authordefault
on

A report by PricewaterhouseCoopers LLP forecast that higher temperatures could lead to a doubling of the world pharmaceutical market in 13 years , with sales of medicines increasing to $1.3 trillion US from about $600 billion last year โ€“ provided drug makers find innovativeย treatments.

The New York-based accounting and consulting company, citing the Intergovernmental Panel on Climate Change, said the average temperature is projected to increase by 0.4 degrees Celsius during the next two decades and the increase could be greater if greenhouse-gas emissionsย increase.

Climate change may already be playing a role in reports of malaria in countries such as Turkey and Georgia where it was eradicated, the reportย said.

authordefault
Admin's short bio, lorem ipsum dolor sit amet consectetur adipisicing elit. Voluptate maxime officiis sed aliquam! Lorem ipsum dolor sit amet consectetur adipisicing elit.

Related Posts

Analysis
on

The Reform chair has long expressed his admiration for the DOGE chief, and is now trying to replicate his policies in local government.

The Reform chair has long expressed his admiration for the DOGE chief, and is now trying to replicate his policies in local government.
on

Farageโ€™s right-hand man has been accused of awarding himself sweeping, unchecked authority within the party.

Farageโ€™s right-hand man has been accused of awarding himself sweeping, unchecked authority within the party.
on

Australiaโ€™s Woodside approves $17.5 billion LNG project just days before Trump social services budget cuts, leaving locals facing โ€œharsh economic reality.โ€

Australiaโ€™s Woodside approves $17.5 billion LNG project just days before Trump social services budget cuts, leaving locals facing โ€œharsh economic reality.โ€
on

Even as the mood at Edmontonโ€™s annual expo turned cautious, industry still bet on public dollars to keep its net zero dream alive.

Even as the mood at Edmontonโ€™s annual expo turned cautious, industry still bet on public dollars to keep its net zero dream alive.